185 completed, 66 unknown, 53 recruiting, 19 active not recruiting. 221 Not applicable, 23 Phase 2, 19 Phase 3, 15 Phase 4, 6 Phase 1.
Follow Université de Sherbrooke: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Virtual Reality for Pain and Well-Being in Older Adults Virtual Reality-Supported Rehabilitation, Usual Care - Chronic Pain, Kinesiophobia (Fear of Movement) | Not applicable | Recruiting | Laval University | 24 | 2026-09-14 | 2026-09-10 |
| Immersive Virtual Reality for Older Adults in Long-Term Care Settings Adapted Virtual Reality Mindfulness Meditation Program, Usual Care - Cognitive Impairment, Long-term Care Centres for Old Adults Users | Not applicable | Recruiting | Laval University | 24 | 2026-09-14 | 2026-09-10 |
| How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver Imaging PET/MRI, Stable isotope infusions, meal test - Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH) | Not applicable | Not yet recruiting | Université de Sherbrooke | 32 | 2026-09-01 | 2025-08-21 |
| Pain Beliefs and Intracortical Excitability During Experimental Pain Topical Capsaicin Cream (1%) - Kinesiophobia (Fear of Movement), Experimental Pain | Not applicable | Not yet recruiting | Université de Sherbrooke | 30 | 2026-08-01 | 2026-07-07 |
| Manual Intervention and Congenital Hip Dysplasia in Infants Manual therapy - Developmental Dysplasia of the Hip (DDH), Congenital Hip Dysplasia | Not applicable | Not yet recruiting | Université de Sherbrooke | 30 | 2026-08-01 | 2026-08-11 |
| Improving Access to Pelvic Health Physiotherapy for Endometriosis Endometriosis | Recruiting | Université de Sherbrooke | 264 | 2026-07-28 | 2026-07-30 | |
| Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. Niacin (250mg), Placebo Oral Tablet - Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Liver Fibrosis/NASH | Not applicable | Recruiting | Université de Sherbrooke | 36 | 2026-06-22 | 2026-07-02 |
| Female Reproductive Health in Canadian Armed Forces Pregnancy, Pelvic Floor Dysfunction | Recruiting | Université de Sherbrooke | 1121 | 2026-05-19 | 2026-05-22 | |
| Therapeutic Climbing for Children With DCD CO-OP-based group therapeutic climbing intervention - Developmental Coordination Disorder (DCD) | Not applicable | Not yet recruiting | Université de Sherbrooke | 16 | 2026-05-15 | 2026-06-01 |
| Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse Real dry needling, Sham dry needling - Provoked Vestibulodynia | Not applicable | Recruiting | Université de Sherbrooke | 170 | 2026-05-11 | 2026-05-12 |
| Group Medical Visits for Patients With Dyslipidemia Group medical visits - Dyslipidemias | Not applicable | Recruiting | Université de Sherbrooke | 288 | 2026-04-01 | 2026-04-22 |
| REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes Knee Extension Brace (Zimmer-type), Early Mobilization (Standard Care) - Total Knee Arthroplasty | Not applicable | Recruiting | Université de Sherbrooke | 106 | 2026-03-03 | 2026-04-06 |
| Thyroid Artery Embolization for the Treatment of Compressive Goiters. Thyroid Artery Embolization - Thyroid Nodules | Not applicable | Recruiting | Université de Sherbrooke | 20 | 2026-01-31 | 2026-01-22 |
| A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma Dupilumab Prefilled Syringe, Placebo Injection - Asthma Control | Phase 3 | Recruiting | Université de Sherbrooke | 150 | 2026-01-29 | 2026-10-02 |
| The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting Placebo, Fluconazole 150 mg - Cardiovascular | Not applicable | Recruiting | Université de Sherbrooke | 40 | 2025-11-01 | 2026-04-13 |
| Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold-induced Shivering Thermogenesis Cold exposure with shivering - Type 2 Diabetes | Not applicable | Recruiting | Université de Sherbrooke | 15 | 2025-09-24 | 2026-05-07 |
| Outdoor Science Education and Child Well-being in Primary Schools: Protocol for a Cluster Randomized Controlled Trial on Learning, Connection to Nature, Eco-anxiety, and Stress Outdoor science education, Indoor classroom-based science education - Healthy Children | Not applicable | Recruiting | Université de Sherbrooke | 1000 | 2025-09-02 | 2025-12-31 |
| Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome CBD Oral Solution, Placebo - Fragile X Syndrome | Phase 2 | Recruiting | Université de Sherbrooke | 40 | 2025-09-01 | 2026-08-28 |
| Virtual Reality and Cranial Nerve Non-invasive Neuromodulation to Improve Quality of Life for Veterans Virtual reality, Cranial nerve non-invasive neuromodulation (CN-NINM), Sham CN-NINM - Chronic Pain, PTSD - Post Traumatic Stress Disorder | Not applicable | Not yet recruiting | Université de Sherbrooke | 30 | 2025-09-01 | 2025-08-29 |
| Recovery With Exogenous Ketones and Antipsychotics Medium chain triglyceride oil - First Episode Psychosis | Not applicable | Recruiting | Université de Sherbrooke | 15 | 2025-08-26 | 2026-05-22 |
Showing 20 of 347. Sign in to see all of them.
Motor Activity (23) · Obesity (21) · Ketosis (19) · Chronic Pain (17) · Diabetes Mellitus, Type 2 (12) · Pain (12) · Diabetes, Gestational (10) · Stroke (10) · Anxiety Disorders (8) · Asthma (8) · Alzheimer Disease (7) · Depression (7) · Inflammation (7) · Vulvodynia (7) · Arthritis, Rheumatoid (6)
Transcranial Direct Current Stimulation (7) · Exercise (6) · Niacin (5) · Transcutaneous Electric Nerve Stimulation (5) · Motivational Interviewing (4) · Calorimetry, Indirect (3) · Control Groups (3) · Docosahexaenoic Acids (3) · Glucose Tolerance Test (3) · High-Intensity Interval Training (3) · Magnetic Resonance Spectroscopy (3) · Physical Therapy Modalities (3) · Adalimumab (2) · Ascorbic Acid (2) · Biopsy (2)
Canada (313) · United Kingdom (3) · United States (3) · France (2) · Australia (1) · Ghana (1) · Guinea (1) · Ireland (1) · New Zealand (1) · Singapore (1) · Switzerland (1) · Togo (1)
Jean-Luc Ardilouze, MD, PhD (9) · Jean-Charles Pasquier, MD, PhD (8) · Stephen Cunnane, PhD (7) · Marie-France Langlois, MD (6) · Guillaume Leonard, PhD (3) · Marie-Helene Milot, PhD (3) · Melanie Plourde, PhD (3) · Michel Tousignant, PhD (3) · Nathaly Gaudreault, PhD (3) · Stephen Cunnane, Ph.D. (3) · Yannick Tousignant-Laflamme, PhD (3)
PMID 41314665, PMID 28487349, PMID 33870714, PMID 41997677, PMID 15689731, PMID 17128343, PMID 17225722, PMID 17356531, PMID 19486033, PMID 19534336, PMID 19760366, PMID 19927537, PMID 20004784, PMID 20143649, PMID 20539245, PMID 21205384, PMID 21489843, PMID 21864137, PMID 21864865, PMID 22284691, PMID 22338607, PMID 22530610, PMID 22931705, PMID 22947543, PMID 23249699, PMID 23334782, PMID 23343392, PMID 23391214, PMID 23504379, PMID 23620304, PMID 23667834, PMID 23844725, PMID 24026531, PMID 24228627, PMID 24239340, PMID 24725226, PMID 24780062, PMID 24811018, PMID 24811020, PMID 24813248, PMID 24829492, PMID 24947313, PMID 25011951, PMID 25215127, PMID 25227179, PMID 25677596, PMID 25820033, PMID 26032476, PMID 26095285, PMID 26112147
R01DA045713 (1), R01DK112260 (1)